Persistent High‐Risk HPV Infection and Molecular Changes Related to the Development of Cervical Cancer
Case Reports in Obstetrics and Gynecology · 2020-01 · 2020 (1)
DOI: 10.1155/2020/6806857 ↗Kurz gefasst
Fallbericht in der Zeitschrift Case Reports in Obstetrics and Gynecology, online erschienen am 23.07.2020. Verfasst von Pablo Moreno-Acosta und 12 weiteren Autor:innen. Beteiligte Einrichtung: Research Group in Radiobiology Clinical, Molecular and Cellular, National Cancer Institute, Bogota, Colombia. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This article is a preliminary investigational study that is aimed at giving hints about the interesting biomarkers involved in the transition process from low‐grade cervix lesion to invasive cervical cancer. Our study focuses on the risk factors and tumour molecular changes in one patient. First in 1986, she was diagnosed a preinvasive cervix lesion. Then, 16 years later, she was diagnosed an invasive cervical cancer. The 2002 diagnosis was a squamous cell carcinoma of the cervix, stage IIIB (FIGO), whereas in 1986, she had been diagnosed a high‐grade squamous intraepithelial cervical lesion. Retrospectively, the analysis of samples of preneoplastic lesions and invasive cervical cancer confirmed the histopathological diagnoses and detected the presence of HPV type and HPV‐16 variants, as well as the overexpression of proteins such as hTERT, IGF1R α , IGF1R β , CAIX, and GLUT1. Finally, the Arg72Pro polymorphism was detected in TP53. The role of high‐risk HPV and HPV‐16 variants and of hTERT, IGF1R α , IGF1R β , CAIX, and GLUT1 variations seemed confirmed in the development and progression of cervical cancer. As a result, analyzing the molecular changes in one and same tumour that progresses from a low‐grade cervix lesion to invasive cervical cancer could provide valuable information in order to improve detection, diagnosis, and treatment in the future.
Autor:innen und Institutionen
- Research Group in Radiobiology Clinical, Molecular and Cellular, National Cancer Institute, Bogota, Colombia.
- Research Group in Cancer Biology, National Cancer Institute, Bogota, Colombia.
- Group of Pathology Oncology, National Cancer Institute, Bogota, Colombia.
- Department of Radiation Oncology, Institut de cancérologie de la Loire-Lucien Neuwirth, 108 bis, Avenue Albert Raimond, BP 60008, 42271 Saint-Priest en Jarez, France.
- Biobank, Group of Pathology Oncology, National Cancer Institute, Bogota, Colombia.
- Pathology Group, National University of Colombia, Bogota, Colombia.
ORCID-Profile: Nicolas Magne
Zitieren
APA
Moreno-Acosta, P., Romero-Rojas, A., Vial, N., Huertas, A., Acosta, J., Mayorga, D., Carrillo, S., Molano, M., Gamboa, O., Cotes, M., Casadiego, C., Vallard, A., & Magne, N. (2020). Persistent High‐Risk HPV Infection and Molecular Changes Related to the Development of Cervical Cancer. Case Reports in Obstetrics and Gynecology, 2020(1). https://doi.org/10.1155/2020/6806857
Vancouver
Moreno-Acosta P, Romero-Rojas A, Vial N, Huertas A, Acosta J, Mayorga D, et al. Persistent High‐Risk HPV Infection and Molecular Changes Related to the Development of Cervical Cancer. Case Reports in Obstetrics and Gynecology. 2020;2020(1). doi:10.1155/2020/6806857
BibTeX
@article{MorenoAcosta2020,
author = {Moreno-Acosta, Pablo and Romero-Rojas, Alfredo and Vial, Nicolas and Huertas, Antonio and Acosta, Jinneth and Mayorga, Diana and Carrillo, Schyrly and Molano, Monica and Gamboa, Oscar and Cotes, Martha and Casadiego, Camila and Vallard, Alexis and Magne, Nicolas},
title = {Persistent High‐Risk HPV Infection and Molecular Changes Related to the Development of Cervical Cancer},
journal = {Case Reports in Obstetrics and Gynecology},
year = {2020},
volume = {2020},
number = {1},
doi = {10.1155/2020/6806857}
}
EUVIMED